AstraZeneca, Prilosec and Nexium: Marketing Challenges in the Launch of a Second-Generation Drug
This entry was posted
on Monday, November 27th, 2006 at 3:37 PM and is filed under Cases and Teaching Notes.
You can follow any responses to this entry through the RSS 2.0 feed.
You can leave a response, or trackback from your own site.
